CLINICAL AUDIT. The laboratory investigation of. UTI in females. in primary care

Similar documents
CLINICAL AUDIT. The Safe and Effective Use of Warfarin

Consultation Group: See relevant page in the PGD. Review Date: October 2015

To Dip or Not To Dip a patient centred approach to improve the management of UTIs in the Care Home environment

Participant Information Sheet Main Trial. ATAFUTI A Trial Investigating Alternative Treatments for Adult Female Urinary Tract Infection

Is It Really a UTI? Do You Know It When You See It?

Nursing Home Pearls or

The Urine Dipstick: A Quick Way To Over-Treat! Ann McFeeters, RN Infection Control Practitioner September 26, 2012

CAUTI reduction at Mayo Clinic

International Journal of Scientific and Research Publications, Volume 4, Issue 1, January ISSN

To Dip or Not To Dip

Urinary Tract Infection (UTI) Program: Implementation Guide, 2 nd Edition. Reducing Antibiotic Harms in Long-term Care

Welcome and thank you for viewing What s your number? Understanding the Long- Stay Urinary Tract Infection Quality Measure. This presentation is one

Medicines and the kidney Community pharmacy s contribution to reducing harm associated with AKI

Adult Protocol Intermittent Catheterisation

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FMD. Patient s first names.

Quality standard Published: 16 July 2013 nice.org.uk/guidance/qs36

Contents. Introduction 3. Required knowledge and skills 4. Section One: Knowledge and skills for all nurses and care staff 6

Author's response to reviews

Adult Protocol Urethral Catheterisation

Indwelling Catheter Care: Areas for Improvement

This matter was initiated by a letter from the complainant received on March 20, A response from Dr. Justin Clark was received on May 11, 2017.

Advanced Measurement for Improvement Prework

Clinical Intervention Overview: Objectives

Protocol: Name of supervising ED provider: Name of RDTC Faculty: Disposition: Date: / / Time: : (military)

Surveillance of Health Care Associated Infections in Long Term Care Settings. Sandra Callery RN MHSc CIC

HIMSS Submission Leveraging HIT, Improving Quality & Safety

MIU Urinary tract infections in females- management of. Clinical Director of Pharmacy

Using Electronic Health Records for Antibiotic Stewardship

RNZCGP Aiming for Excellence (CORNERSTONE ) and Annual Program. PMAANZ Conference, Rotorua 6 th September 2014 Rosemary Gordon

Open and Honest Care in your Local NHS Trust

APPLICATION FORM (do not alter this form in any way)

Audit of Cervical Samples Taken in General Practice

Open and Honest Care in your Local Hospital

Tools & Resources for QI Success

Learning Objectives. QAPI at a Glance: 8/22/16. Achieving Success with QAPI. Participants will be able to describe:

Open and Honest Care in your Local Hospital

Proactive Care Team Contingency Plan Original completed: Patient Details. Frameworki Number: First Name: Margaret Lives Alone: Yes No

Patient survey report Survey of people who use community mental health services 2011 Pennine Care NHS Foundation Trust

Quality Measures and the Five-Star Rating

Please call the Pharmacy Medicines Unit on or for a copy.

Applicant Information Sheet for MASS 50 Continence Aids: Initial and Review Application

Open and Honest Care in your Local Hospital

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX)

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM VISMODEGIB. Patient s first names.

Open and Honest Care in your Local Hospital

Bladder Instillation Therapy (Mitomycin) Department of Urology Information for patients

Continence & Catheter Training For Nursing Homes For Jan-June 2016

Open and Honest Care in your Local Hospital

Job Title Name Signature Date

CYSTOSCOPY AND URETHRAL BULKING INJECTIONS

Open and Honest Care in your Local Hospital

Infection Control Quality Assurance & Performance Improvement (QAPI) Case Study Scenario 1: Following Quality Assurance (QA)

Patient identifier/label: Page 1 of 6. Patient s first names. Date of birth

CMS and NHSN: What s New for Infection Preventionists in 2013

Patient survey report 2004

PATIENT GROUP DIRECTION (PGD) FOR Metronidazole 400mg Tablets

Open and Honest Care in your Local Hospital

Polling Question #1. Denials and CDI: A Recovery Auditor s Perspective

Open and Honest Care in your Local Hospital

Oral Ibrutinib (single agent)

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM TRASTUZUMAB (HERCEPTIN) Patient s first names.

Agenda: Noon Overview of the regulatory sections affected by the Reform of RoP in Phase 2

Open and Honest Care in your Local Hospital

xrfslt \j,3 0+ {6^1 Otc(L!?i:lr+ NHS FIFE PRIMARY CARE THIS PATIENT GROUP DIRECTION HAS BEEN APPROVED BY:

Patient survey report Outpatient Department Survey 2011 County Durham and Darlington NHS Foundation Trust

Development and assessment of a Patient Safety Culture Dr Alice Oborne

The Primary Care Trigger Tool: Practical Guidance

Open and Honest Care in your Local Hospital

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.

Open and Honest Care in your Local Hospital

Open and Honest Care in your Local Hospital

PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK

Patient survey report Outpatient Department Survey 2009 Airedale NHS Trust

Vocational Rehabilitation Needs Assessments Version 3.0 August 2016

Antimicrobial Stewardship Program in the Nursing Home

Emerging Outpatient CDI Drivers and Technologies

CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE

Open and Honest Care in your Local Hospital

Medical Council of New Zealand

ED Care Triage: Linkage to Primary Care

Open and Honest Care in your Local Hospital

Challenges and implications of patient reported clinical outcomes for randomised controlled trials

Christine McMillan and Prof. Glenda Cook Roy Marston, Jo Rose & Dr Cathy Bailey

Section 11. Adverse Event Reporting and Safety Monitoring

Ensuring quality outcomes

PATIENT AGREEMENT TO SYSTEMIC THERAPY: GENERIC CONSENT FORM. Patient s first names. Date of birth. Job title

Open and Honest Care in your Local Hospital

Open and Honest Care in your local Trust. Open and Honest Report for. Black Country Partnership NHS Foundation Trust

Practice Handbook for Designated Medical Practitioners

Standard Work: Triage

Oklahoma Health Care Authority. ECHO Adult Behavioral Health Survey For SoonerCare Choice

Remove catheters as soon as possible, care for catheters individually

Indwelling Urinary Catheters: A One- Point Restraint?

Overview of Revised LTC Surveillance Definitions

Indicator 22 Patient records meet requirements to describe and support the management of health care provided.

INTRODUCTION. Criteria and definition of infection Data submission template Example of a quarterly report Program guidelines & enrollment form

Clinical Skills Passport for Relief and Temporary Staff in Neonatal Units

Older Person's Assessment Form. Name: Contact details: Provide detail: Detail: Detail: Detail: Detail:

Delayed discharges and unplanned admissions from the Day Care Unit at Mater Dei Hospital, Malta

Level 3 Certificate in Clinical Skills ( )

Transcription:

CLINICAL AUDIT The laboratory investigation of UTI in females in primary care Valid to December 2018 bpac nz better medicin e

Background Approximately 50% of all females will have a urinary tract infection (UTI) in their lifetime. Most females with UTI will have an uncomplicated infection that does not require urine culture. Avoiding unnecessary urine testing can reduce the burden on laboratories and decrease costs without compromising care. Uncomplicated UTI An uncomplicated UTI is any UTI occurring in an adult female who is not pregnant and has a normal genitourinary tract and a routine presentation (Table 1). For females with uncomplicated UTI appropriate management is empirical treatment with trimethoprim, 300 mg, once daily, for three days, with follow up if symptoms persist or recur. Urine culture * is not necessary for females with uncomplicated lower UTI as it does not improve outcomes. * Sentinel urine cultures may be appropriate in some circumstances, however, the local laboratory will usually indicate this. Complicated UTI A complicated UTI is any UTI occurring in a female who does not have classic UTI symptoms or who is known to have a genitourinary tract abnormality. UTIs in males or in children are also regarded as complicated (Table 1). A urine culture is indicated for people with a complicated UTI. The request for urine culture should not delay the initiation of empirical antibiotic therapy. The results of the culture may help to confirm the choice of antibiotic, or indicate that a change of antibiotic is required Audit plan Summary This audit focuses on females aged between 15 55 years. When a female within this age group presents with symptoms of UTI such as dysuria, frequency, urgency or suprapubic pain with no other complicating factors, an uncomplicated UTI is likely. In this group, empirical antibiotic treatment is indicated and there is no indication for urine culture. If a female had features that indicate the UTI may be complicated, urine culture is appropriate. Criteria for a positive outcome A positive result is any female aged 15 55 years, who: A. Did not have a urine culture requested, and had an uncomplicated UTI, OR; B. Had a urine culture requested, and had a complicated UTI Recommended audit standards A recommended audit standard for this audit is for 80% of females aged 15 55 years who have had a UTI in the previous twelve months to have either had no urine culture requested, or if a urine culture was requested, had an indication recorded in their notes that justifies the test. Table 1: The features of an uncomplicated and complicated UTI Uncomplicated Dysuria Frequency Urgency Suprapubic pain Complicated UTI in: Women who are pregnant Males Children Suspected pyelonephritis Recurrent UTIs Failed antibiotic treatment or persistence despite treatment Patients with a catheter People with abnormalities of the genitourinary tract People with renal impairment For further information see: Antibiotics Guide: Choices for common infections, BPJ Supplement (Jul, 2013). The Laboratory Investigation of UTI in Females in Primary Care Clinical Audit

Data Eligible people Any female enrolled in the practice aged 15 55 years who received a prescription for trimethoprim in the previous twelve months is eligible for this audit. N.B. If a sentinel urine culture has been requested by the local laboratory for females with uncomplicated UTI, exclude these patients from the audit. Identifying patients You will need to have a system in place that allows you to identify these eligible patients. Many practices will be able to identify patients by running a query through their PMS system. Identify all female patients aged 15 55 years who have received a prescription for trimethroprim in the previous twelve months. Trimethroprim is being used as a proxy measure for UTI in a female, as not all practices will code every case of UTI with a Read code in the clinical records. Some patients may be missed, but searching for trimethoprim should identify the majority of females with a UTI seen in primary care. Sample size The number of eligible patients will vary according to your practice demographic. If you identify a large number of patients, take a random sample of 20-30 patients whose notes you will audit (or the first 20-30 results returned). Data analysis Use the data sheet to record your data. A positive result is any patient who has a either a Yes in column A and a Yes in column B or a No in column A and a No in Column B. Any patient who does not have two Yes or two No answers recorded is a negative result. Identifying opportunities for CQI Taking action The first step to improving medical practice is to identify the criteria where gaps exist between expected and actual performance and then to decide how to change practice. Decide on a set of priorities for change and develop an action plan to implement any changes. It may be useful to consider the following points when developing a plan for action. Problem solving process What is the problem or underlying problem(s)? Change it to an aim What are the solutions or options? What are the barriers? How can you overcome them? Overcoming barriers to promote change What is achievable find out what the external pressures on the practice are and discuss ways of dealing with them in the practice setting Identify the barriers Develop a priority list Choose one or two achievable goals Effective interventions No single strategy or intervention is more effective than another, and sometimes a variety of methods are needed to bring about lasting change Interventions should be directed at existing barriers or problems, knowledge, skills and attitudes, as well as performance and behaviour Calculate your percentage achievement by adding up the number of positive results (those with a tick in column C) and dividing this number by the total number of patients audited. Clinical Audit The Laboratory Investigation of UTI in Females in Primary Care

Review Monitoring change and progress It is important to review the action plan against the timeline at regular intervals. It may be helpful to consider the following questions: Is the process working? Are the goals for improvement being achieved? Are the goals still appropriate? Do you need to develop new tools to achieve the goals you have set? Following the completion of the first cycle, it is recommended that the doctor completes the first part of the CQI activity summary sheet. Undertaking a second cycle In addition to regular reviews of progress, a second audit cycle should be completed in order to quantify progress on closing the gaps in performance. It is recommended that the second cycle be completed within 12 months of completing the first cycle. The second cycle should begin at the data collection stage. Following the completion of the second cycle it is recommended that doctors complete the remainder of the CQI activity summary sheet. Claiming MOPS credits This audit has been endorsed by the RNZCGP as a CQI Activity for allocation of MOPS credits. General practitioners taking part in this audit can claim credits in accordance with the current MOPS programme. This status will remain in place until December 2018. To claim points for MOPS or CPD online please enter your credits on your web records. Go to the RNZCGP website www.rnzcgp.org.nz and claim your points on MOPS online for vocationally registered doctors, or CPD online for general registrants. Alternatively MOPS participants can indicate completion of the audit on the annual credit summary sheet which is available from the College on request. As the RNZCGP frequently audit claims you should retain the following documentation, in order to provide adequate evidence of participation in this audit: 1. A summary of the data collected 2. A Continuous Quality Improvement (CQI) Activity summary sheet bpac nz 10 George Street PO Box 6032, Dunedin phone 03 477 5418 free fax 0800 bpac nz bpac nz better medicin e www.bpac.org.nz December 2013

Data sheet cycle 1 Audit: The laboratory investigation of UTI in females in primary care A B C Patient Was a urine culture requested? (Yes/No) Do the patient notes indicate that the UTI was complicated? (Yes/No) Positive result? (Yes/Yes or No/No) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Total Positive Results: 100 = Total Positive Results Total No. Patients Please retain this sheet for your records to provide evidence of participation in this audit %

Data sheet cycle 2 Audit: The laboratory investigation of UTI in females in primary care A B C Patient Was a urine culture requested? (Yes/No) Do the patient notes indicate that the UTI was complicated? (Yes/No) Positive result (Yes/Yes or No/No) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Total Positive Results: 100 = Total Positive Results Total No. Patients Please retain this sheet for your records to provide evidence of participation in this audit: %

RNZCGP Summary Sheet CQI Activity DOCTORS NAME The activity was designed by (please tick appropriate box): RNZCGP Organisation e.g. IPA/PHO/BPAC (name of organisation) Individual (self) bpac nz TOPIC The laboratory investigation of UTI in females in primary care Describe why you chose this topic (relevance, needs assessment etc): FIRST CYCLE 1. DATA Information collected Date of data collection: Please attach: A summary of data collected or If this is an organisation activity, attach a certificate of participation. 2. CHECK Describe any areas targeted for improvement as a result of the data collected. 3. ACTION Describe how these improvements will be implemented. 4. MONITOR Describe how well the change process is working. When will you undertake a second cycle? Please retain this sheet for your records to provide evidence of participation in this audit:

SECOND CYCLE 1. DATA Information collected Date of data collection: Please attach: A summary of data collected or If this is an organisation activity, attach a certificate of participation. 2. CHECK Describe any areas targeted for improvement as a result of the data collected. w 3. ACTION Describe how these improvements will be implemented. 4. MONITOR Describe how well the change process is working. Will you undertake another cycle? COMMENTS Please retain this sheet for your records to provide evidence of participation in this audit: